CNAT

Conatus Pharmaceuticals (CNAT)

Conatus Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CNAT

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2020/06/06	05 : 03	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/06/01	21 : 02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/30	05 : 11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/30	05 : 10	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/29	08 : 56	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/29	08 : 56	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/29	08 : 55	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/29	08 : 54	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/29	08 : 52	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/29	08 : 51	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/29	08 : 51	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/29	08 : 50	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/29	08 : 48	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/29	08 : 47	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/29	08 : 46	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/29	08 : 45	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/29	08 : 43	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/29	08 : 42	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/29	08 : 41	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/29	08 : 40	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/28	21 : 30	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/27	21 : 42	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/27	19 : 10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/27	19 : 07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/27	19 : 06	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/22	05 : 13	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/19	05 : 11	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/18	21 : 00	GlobeNewswire Inc.	Leading Independent Proxy Advisory Firms Recommend Conatus Pharmaceuticals Shareholders Vote in Favor of its Merger with Hist...	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/15	05 : 07	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:CNAT	Conatus Pharmaceuticals Inc
2020/05/14	21 : 00	GlobeNewswire Inc.	Histogen Publishes Preclinical Data on its HST 004 Spinal Disc Program	NASDAQ:CNAT	Conatus Pharmaceuticals Inc